Yoga Module Development and Validation for Sickle Cell Disease

Author:

Zaidi Syed Zaeem Haider1,Mithila M.V1,Mavathur Ramesh Nanjundaiah1,Nagarathna R.2,Thulasi Arun3,Ramsahaye Atmika Y.3,Naresh Katla3,Shukla Himanshu A.1

Affiliation:

1. Division of Yoga and Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bangalore, Karnataka, India

2. Medical Director of Arogyadhama, Prashanti Kuteeram, Division of Yoga and Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bangalore, Karnataka, India

3. Division of Yoga and Humanities, Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bangalore, Karnataka, India

Abstract

Abstract Introduction: Sickle cell disease (SCD) is a genetic blood disorder that affects the shape and function of red blood cells (RBCs), which can lead to several health problems affecting the quality of life. SCD can be treated with certain expensive treatments such as RBC transfusion, hydroxyurea, stem cell transplantation, gene therapy, or bone marrow transplant. However, some of the most common symptoms such as pain, anxiety, and stress can also be alleviated with alternative therapies like yoga. In light of this, there is a need for the development of a specific yoga module (YM) for SCD that can complement the current therapies. Objective: To develop and validate a YM for SCD. Methodology: Concise literature reports on yoga practices used for varied symptoms/comorbidities associated with SCD were compiled and presented to focus groups. Based on the presented report and personal experience, the focus group created a preliminary version of the module. The preliminary module was further refined based on content validity ratio (CVR) following module validation by 33 yoga experts. Results: One hour ten minutes module developed by the focus group had in total 27 practices including, loosening exercises, asanas, pranayama, relaxation techniques, and meditation. After validation by the experts, 21 practices with a CVR ≥ 0.33 were retained. The predominant reason for excluding 12 practices was intensity, which may have some adverse effect on sickle cell comorbidities. Conclusion: The module developed is the first validated module for SCD.

Publisher

Medknow

Reference45 articles.

1. The spatial epidemiology of sickle-cell anaemia in India;Hockham;Sci Rep,2018

2. Sickle cell disease in tribal populations in India;Colah;Indian J Med Res,2015

3. Advances in the diagnosis and treatment of sickle cell disease;Brandow;J Hematol Oncol,2022

4. Environmental determinants of severity in sickle cell disease;Tewari;Haematologica,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3